Akèy › Neuropathies sensorielles et autonomes héréditaires
Etid klinik pou Neuropathies sensorielles et autonomes héréditaires ap rekrite nan Etazini
21 etid pou Neuropathies sensorielles et autonomes héréditaires ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- San Antonio, TX7 etid
- Arlington, VA7 etid
- Nashville, TN6 etid
- Boston, MA6 etid
- New York City, NY6 etid
- Houston, TX5 etid
- Philadelphia, PA5 etid
- Washington, DC4 etid
- Ann Arbor, MI4 etid
- Portland, OR4 etid
- Pittsburgh, PA4 etid
- Aurora, CO3 etid
- Los Angeles, CA3 etid
- San Francisco, CA3 etid
- Charlotte, NC3 etid
- Cincinnati, OH3 etid
- Denver, CO3 etid
Pa eta
- Arizona3 etid
- Colorado7 etid
- Distrik Columbia3 etid
- Florid7 etid
- Kalifòni9 etid
- Maryland5 etid
- Massachusetts6 etid
- Michigan5 etid
- Minnesota3 etid
- Missouri3 etid
- New York8 etid
- North Carolina5 etid
- Ohio6 etid
- Oregon6 etid
- Pennsylvania9 etid
- Tennessee6 etid
- Texas11 etid
- Virginia7 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT046451609-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06896188Study of ACR-2316 in Specific Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06667141Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT04038502A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Aug 10, 2026 · NCT07175038A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07749586Pancreatic Cancer Registry: For Any Person With a Personal or Family History
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT02886247A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT04657068Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 23, 2026 · NCT01238250First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07558733Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT06993844A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT05010031A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Ap rekriteFaz 1
Laj 18 ak plis · Fanm · Mizajou Apr 22, 2026 · NCT05683418Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
Ap rekriteEtid obsèvasyon
Laj 1 a 100 · Tout sèks · Mizajou Apr 1, 2026 · NCT05868629A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
Ap rekriteFaz 1
Laj 18 a 110 · Tout sèks · Mizajou Mar 2, 2026 · NCT07064122Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 26, 2026 · NCT06599619Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Dec 24, 2025 · NCT06463028The Natural History of Familial Dysautonomia
Ap rekriteEtid obsèvasyon
Laj 4 ak plis · Tout sèks · Mizajou Nov 10, 2025 · NCT03920774The Cancer of the Pancreas Screening-5 CAPS5)Study
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 9, 2025 · NCT02000089Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 29, 2025 · NCT01793168Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.